The first Union list of critical medicines by Giuliana Miglierini The first version of the Union list of critical medicines was published on 12 December…
The drug shortage situation – EIPG’s point of view by Maurizio Battistini The shortage of medicines has been a major concern in the countries of the European…
EMA’s reflection paper on AI in the pharmaceutical lifecycle by Giuliana Miglierini The rapidly evolving role of artificial intelligence (AI) and its possible application in the pharmaceutical…
EMA’s recommendations to prevent medicines shortages By Giuliana Miglierini Continuity of medicinal product supply is still representing a key issue for European countries. The…
ACT EU’s Workplan 2022-2026 by Giuliana Miglierini The implementation phase of the Accelerating Clinical Trials in the EU (ACT EU) initiative, launched…
ACT EU: the EU’s vision for the future of clinical trials by Giuliana Miglierini Just few days before the entry into force of the new Clinical Trials Regulation and…